On June 5, GlobeNewswire reported that the U.S.-listed pharmaceutical company Silo Pharma (Nasdaq: SILO) The board of directors has approved the purchase of bitcoin worth up to $1 million as a reserve asset. Silo Pharma CEO Eric Weisblum said the inclusion of Bitcoin in the company’s reserves is a strategic decision that will diversify assets through a digital store of value and serve as a safeguard against inflation, a move that Silo Pharma expects will optimize long-term shareholder value.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
The board of directors of the US pharmaceutical company Silo Pharma approved the purchase of 1 million dollars worth of Bitcoin as reserve assets.
On June 5, GlobeNewswire reported that the U.S.-listed pharmaceutical company Silo Pharma (Nasdaq: SILO) The board of directors has approved the purchase of bitcoin worth up to $1 million as a reserve asset. Silo Pharma CEO Eric Weisblum said the inclusion of Bitcoin in the company’s reserves is a strategic decision that will diversify assets through a digital store of value and serve as a safeguard against inflation, a move that Silo Pharma expects will optimize long-term shareholder value.